Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 2
1994 4
1995 4
1996 4
1997 8
1998 10
1999 3
2000 5
2001 3
2002 18
2003 43
2004 97
2005 103
2006 135
2007 170
2008 196
2009 189
2010 199
2011 214
2012 191
2013 218
2014 183
2015 189
2016 180
2017 181
2018 185
2019 196
2020 191
2021 216
2022 226
2023 210
2024 217
2025 155

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,693 results

Results by year

Filters applied: . Clear all
Page 1
Fibromyalgia: Diagnosis and Management.
Winslow BT, Vandal C, Dang L. Winslow BT, et al. Am Fam Physician. 2023 Feb;107(2):137-144. Am Fam Physician. 2023. PMID: 36791450 Free article.
Patient education, exercise, and cognitive behavior therapy can improve pain and function. Duloxetine, milnacipran, pregabalin, and amitriptyline are potentially effective medications for fibromyalgia. ...
Patient education, exercise, and cognitive behavior therapy can improve pain and function. Duloxetine, milnacipran, pregabalin, and a …
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy.
Jang HN, Oh TJ. Jang HN, et al. Diabetes Metab J. 2023 Nov;47(6):743-756. doi: 10.4093/dmj.2023.0018. Epub 2023 Sep 6. Diabetes Metab J. 2023. PMID: 37670573 Free PMC article. Review.
Food and Drug Administration (FDA) has approved pregabalin, duloxetine, tapentadol, and the 8% capsaicin patch as drugs for the treatment of painful DPN. ...
Food and Drug Administration (FDA) has approved pregabalin, duloxetine, tapentadol, and the 8% capsaicin patch as drugs for the treat …
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions.
Fagan HA, Baldwin DS. Fagan HA, et al. Expert Rev Neurother. 2023 Jun;23(6):535-548. doi: 10.1080/14737175.2023.2211767. Epub 2023 May 15. Expert Rev Neurother. 2023. PMID: 37183813 Free article. Review.
EXPERT OPINION: A range of effective treatments for GAD are available, particularly duloxetine, escitalopram, pregabalin, quetiapine, and venlafaxine. There is a limited evidence base to support the further pharmacological management of patients with GAD who have not respo …
EXPERT OPINION: A range of effective treatments for GAD are available, particularly duloxetine, escitalopram, pregabalin, quetiapine, …
Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis.
Migliorini F, Maffulli N, Eschweiler J, Baroncini A, Bell A, Colarossi G. Migliorini F, et al. J Orthop Surg Res. 2023 Jul 17;18(1):504. doi: 10.1186/s13018-023-03995-z. J Orthop Surg Res. 2023. PMID: 37461044 Free PMC article.
CONCLUSIONS: Duloxetine could help in improving symptoms of fibromyalgia. The dose of duloxetine should be customised according to individual patients. Irrespective of the doses, duloxetine was more effective than placebo in the management of fibromyalgia. Th …
CONCLUSIONS: Duloxetine could help in improving symptoms of fibromyalgia. The dose of duloxetine should be customised accordin …
Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis.
Chow R, Novosel M, So OW, Bellampalli S, Xiang J, Boldt G, Winquist E, Lock M, Lustberg M, Prsic E. Chow R, et al. BMJ Support Palliat Care. 2023 Mar;13(1):27-34. doi: 10.1136/spcare-2022-003815. Epub 2022 Sep 8. BMJ Support Palliat Care. 2023. PMID: 36194493
INTRODUCTION: Duloxetine has previously been reported to be promising in the setting of chemotherapy-induced peripheral neuropathy (CIPN). ...CONCLUSION: There is currently limited evidence supporting duloxetine's use for CIPN. There is a need for more compre …
INTRODUCTION: Duloxetine has previously been reported to be promising in the setting of chemotherapy-induced peripheral neuropathy (C …
Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC. Shelton RC. Handb Exp Pharmacol. 2019;250:145-180. doi: 10.1007/164_2018_164. Handb Exp Pharmacol. 2019. PMID: 30838456
It is approved in the narrow dose range of 50-100 mg per day. Duloxetine is a more potent 5-HT and NE reuptake inhibitor with a more balanced profile of binding at about 10:1 for 5HT and NE transporter binding. ...Clinical trials to date have demonstrated rates of response …
It is approved in the narrow dose range of 50-100 mg per day. Duloxetine is a more potent 5-HT and NE reuptake inhibitor with a more …
Medication-Induced Weight Change Across Common Antidepressant Treatments : A Target Trial Emulation Study.
Petimar J, Young JG, Yu H, Rifas-Shiman SL, Daley MF, Heerman WJ, Janicke DM, Jones WS, Lewis KH, Lin PD, Prentice C, Merriman JW, Toh S, Block JP. Petimar J, et al. Ann Intern Med. 2024 Aug;177(8):993-1003. doi: 10.7326/M23-2742. Epub 2024 Jul 2. Ann Intern Med. 2024. PMID: 38950403 Free PMC article.
Escitalopram, paroxetine, and duloxetine were associated with 10% to 15% higher risk for gaining at least 5% of baseline weight, whereas bupropion was associated with 15% reduced risk. ...Six-month adherence ranged from 28% (duloxetine) to 41% (bupropion). LIMITATIO …
Escitalopram, paroxetine, and duloxetine were associated with 10% to 15% higher risk for gaining at least 5% of baseline weight, wher …
Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J. Fava GA, et al. Psychother Psychosom. 2018;87(4):195-203. doi: 10.1159/000491524. Epub 2018 Jul 17. Psychother Psychosom. 2018. PMID: 30016772
Titles, abstracts, and topics were searched using a combination of the following terms: "duloxetine" OR "venlafaxine" OR "desvenlafaxine" OR "milnacipran" OR "levomilnacipran" OR "SNRI" OR "second generation antidepressant" OR "serotonin norepinephrine reuptake inhibitor" …
Titles, abstracts, and topics were searched using a combination of the following terms: "duloxetine" OR "venlafaxine" OR "desvenlafax …
Bioaccumulation of therapeutic drugs by human gut bacteria.
Klünemann M, Andrejev S, Blasche S, Mateus A, Phapale P, Devendran S, Vappiani J, Simon B, Scott TA, Kafkia E, Konstantinidis D, Zirngibl K, Mastrorilli E, Banzhaf M, Mackmull MT, Hövelmann F, Nesme L, Brochado AR, Maier L, Bock T, Periwal V, Kumar M, Kim Y, Tramontano M, Schultz C, Beck M, Hennig J, Zimmermann M, Sévin DC, Cabreiro F, Savitski MM, Bork P, Typas A, Patil KR. Klünemann M, et al. Nature. 2021 Sep;597(7877):533-538. doi: 10.1038/s41586-021-03891-8. Epub 2021 Sep 8. Nature. 2021. PMID: 34497420 Free PMC article.
As a case in point, we studied the molecular basis of bioaccumulation of the widely used antidepressant duloxetine by using click chemistry, thermal proteome profiling and metabolomics. We find that duloxetine binds to several metabolic enzymes and changes the metab …
As a case in point, we studied the molecular basis of bioaccumulation of the widely used antidepressant duloxetine by using click che …
Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
Bidari A, Moazen-Zadeh E, Ghavidel-Parsa B, Rahmani S, Hosseini S, Hassankhani A. Bidari A, et al. Daru. 2019 Jun;27(1):149-158. doi: 10.1007/s40199-019-00257-4. Epub 2019 Mar 14. Daru. 2019. PMID: 30877484 Free PMC article. Clinical Trial.
BACKGROUND: Duloxetine and pregabalin are among the most widely used medications in the treatment of patients with fibromyalgia syndrome (FM). ...Drop out rate and cumulative incidence of nausea was significantly higher in the duloxetine arm compared to the pregabal …
BACKGROUND: Duloxetine and pregabalin are among the most widely used medications in the treatment of patients with fibromyalgia syndr …
3,693 results